Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.26 -0.30 (-3.14%)
As of: Oct 1, 2026 · 3:59 PM EDT

Xeris Biopharma Holdings (XERS) Accounts Payables (2020 - 2026)

Updated

Xeris Biopharma Holdings (XERS) recorded Accounts Payables of $9.34 million in Q2 2026, down 1.3% from $9.46 million a year earlier and down 18.6% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Accounts Payables (2020 - 2026) Analysis & Trends

At the end of FY2025, Xeris Biopharma Holdings reported Accounts Payables of $3.08 million, up 34.3% from FY2024.

  • Annual Accounts Payables has a five-year compound annual growth rate of -0.3% (FY2020 to FY2025).
  • Across earlier years, Accounts Payables came in at $2.29 million in FY2024 (-80.2%), $11.57 million in FY2023 (+151.1%), $4.61 million in FY2022 (-48.4%) and $8.92 million in FY2021 (+186.3%).
  • Quarterly Accounts Payables has ranged from $2.29 million in Q4 2024 to $12.08 million in Q3 2023 over the past five years.
  • On a year-over-year basis, Accounts Payables rose in three of the last eight quarters, with growth averaging 4.4%.
  • Peak year-over-year performance for Accounts Payables in the last five years was growth of 208.4% in Q3 2023, against a decline of 80.2% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $11.47 million (Q1 2026), $3.08 million (Q4 2025) and $6.53 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Xeris Biopharma Holdings 1.66 Bn 1.22 Bn 79.59 Mn 9.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.34 Mn
Mar 31, 2026 11.47 Mn
Dec 31, 2025 3.08 Mn
Sep 30, 2025 6.53 Mn
Jun 30, 2025 9.46 Mn
Mar 31, 2025 6.35 Mn
Dec 31, 2024 2.29 Mn
Sep 30, 2024 7.45 Mn
Jun 30, 2024 5.80 Mn
Mar 31, 2024 7.09 Mn
Dec 31, 2023 11.57 Mn
Sep 30, 2023 12.08 Mn
Jun 30, 2023 11.62 Mn
Mar 31, 2023 11.98 Mn
Dec 31, 2022 4.61 Mn
Sep 30, 2022 3.92 Mn
Jun 30, 2022 6.63 Mn
Mar 31, 2022 11.09 Mn
Dec 31, 2021 8.92 Mn
Sep 30, 2021 4.29 Mn
API Access

Xeris Biopharma Holdings Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=XERS&period=max&api_key=YOUR_API_KEY